Efficacy of a triplet and doublet-based chemotherapy as first-line therapy in patients with HER2-negative metastatic gastric cancer: a retrospective analysis from the clinical practice
Crossref DOI link: https://doi.org/10.1007/s12032-017-1046-7
Published Online: 2017-10-17
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Laterza, Maria Maddalena
Pompella, Luca
Petrillo, Angelica
Tirino, Giuseppe
Pappalardo, Annalisa
Orditura, Michele
Troiani, Teresa
Ciardiello, Fortunato
Di Martino, Natale
De Vita, Ferdinando http://orcid.org/0000-0002-7654-7470
License valid from 2017-10-17